From a single biopsy, our AI — grounded in real biological rules, not statistics — maps the patient's disease at a molecular level. Then it prioritizes from all approved drugs what will work best, or designs new therapeutic candidates when nothing on the list will work.
Our AI doesn't guess. It understands the molecular logic of disease and uses it to find the right solution for each patient.
A biopsy sample enters our platform. Our AI builds a complete molecular map of the patient's disease — identifying what's broken, why, and what targets can fix it. No statistics. Pure biology.
→ Molecular-level understandingWe screen all approved drugs against the patient's molecular profile. Our AI predicts drug-gene interactions and ranks which treatments will be most effective for this specific biology.
→ Personalized drug prioritizationWhen no approved drug will work, our AI designs novel therapeutic candidates — real, testable molecules grounded in the patient's biology. Not hypotheticals. Ready for our Lab On A Cell to validate.
→ From no options to new solutionsEvery prediction our AI makes traces back to validated biological rules, appreciating whole cell effects. Not just single-target. Not correlations. Not black boxes, not population averages.
Our AI uses mechanistic biological models — enzyme kinetics, metabolic pathways, protein interactions. Every prediction can be explained and traced back to real biology.
Years of curated molecular data — protein structures, catalytic mechanisms, drug-target interactions — that no competitor can replicate. Our predictions carry resolution unavailable elsewhere.
What used to take research teams months of analysis, our platform delivers in hours. From biopsy to complete molecular disease map and drug recommendation — same day.
When our AI designs a new therapeutic candidate, it feeds directly into our Lab On A Cell hardware for physical validation. One platform. No gap between prediction and proof.
Our team will walk you through a live demonstration — from biopsy data to molecular disease map to drug recommendation. See the platform in action on real biology.